Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,808 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.
Kaneko A, Kobayashi N, Miura K, Matsumoto H, Somekawa K, Hirose T, Kajita Y, Tanaka A, Teranishi S, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Watanabe K, Horita N, Hara Y, Kudo M, Miyazawa N, Kaneko T. Kaneko A, et al. Among authors: hara y. Thorac Cancer. 2024 Apr 11. doi: 10.1111/1759-7714.15304. Online ahead of print. Thorac Cancer. 2024. PMID: 38602166 Free article.
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial.
Kobayashi N, Hashimoto H, Kamimaki C, Nagasawa R, Tanaka K, Kubo S, Katakura S, Chen H, Hirama N, Ushio R, Aoki A, Nakashima K, Teranishi S, Manabe S, Watanabe H, Horita N, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Kobayashi N, et al. Among authors: hara y. Thorac Cancer. 2020 Aug;11(8):2125-2129. doi: 10.1111/1759-7714.13503. Epub 2020 Jun 3. Thorac Cancer. 2020. PMID: 32495514 Free PMC article. Clinical Trial.
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer.
Katakura S, Kobayashi N, Hashimoto H, Kamimaki C, Tanaka K, Kubo S, Nakashima K, Teranishi S, Manabe S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Katakura S, et al. Among authors: hara y. Thorac Cancer. 2020 Oct;11(10):2975-2982. doi: 10.1111/1759-7714.13653. Epub 2020 Sep 7. Thorac Cancer. 2020. PMID: 32893980 Free PMC article.
T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer.
Kamimaki C, Kobayashi N, Hirata M, Somekawa K, Fukuda N, Kubo S, Katakura S, Teranishi S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T. Kamimaki C, et al. Among authors: hara y. Thorac Cancer. 2021 Jun;12(11):1726-1734. doi: 10.1111/1759-7714.13978. Epub 2021 May 4. Thorac Cancer. 2021. PMID: 33943031 Free PMC article.
Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%-49%: A network meta-analysis.
Fukuda N, Horita N, Namkoong H, Kaneko A, Somekawa K, Tagami Y, Watanabe K, Hara Y, Kobayashi N, Kaneko T. Fukuda N, et al. Among authors: hara y. Thorac Cancer. 2022 Jan;13(1):84-94. doi: 10.1111/1759-7714.14229. Epub 2021 Nov 17. Thorac Cancer. 2022. PMID: 34791815 Free PMC article.
Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial.
Matsumoto H, Kobayashi N, Somekawa K, Fukuda N, Kaneko A, Kamimaki C, Kubo S, Tanaka K, Tagami Y, Teranishi S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Koizumi H, Miura K, Miyazawa N, Kaneko T. Matsumoto H, et al. Among authors: hara y. Thorac Cancer. 2022 Jan;13(2):228-235. doi: 10.1111/1759-7714.14252. Epub 2021 Dec 5. Thorac Cancer. 2022. PMID: 34866339 Free PMC article.
Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma.
Hirama N, Yamamoto M, Nagaoka S, Segawa W, Sugimoto C, Nagayama H, Hiro S, Kajita Y, Maeda C, Kubo S, Seki K, Nagahara Y, Teranishi S, Tashiro K, Hara Y, Kobayashi N, Watanabe S, Kudo M, Kaneko T. Hirama N, et al. Among authors: hara y. Thorac Cancer. 2023 Sep;14(25):2601-2607. doi: 10.1111/1759-7714.15042. Epub 2023 Aug 2. Thorac Cancer. 2023. PMID: 37533115 Free PMC article.
Clinical significance of Charlson comorbidity index as a prognostic parameter for patients with acute or subacute idiopathic interstitial pneumonias and acute exacerbation of collagen vascular diseases-related interstitial pneumonia.
Murohashi K, Hara Y, Saigusa Y, Kobayashi N, Sato T, Yamamoto M, Kudo M, Kaneko T. Murohashi K, et al. Among authors: hara y. J Thorac Dis. 2019 Jun;11(6):2448-2457. doi: 10.21037/jtd.2019.05.46. J Thorac Dis. 2019. PMID: 31372282 Free PMC article.
2,808 results